In our patient, no IDH mutation was found, which explains the aggressive course of the disease - in fact, IDH-wildtype gliomas with anaplastic features are now classified as glioblastoma (WHO IV) due to similar biology and prognosis [10]. The gene discussed is IDH2; the disease is central nervous system cancer.